A prototype approach toward antipsychotic medication adherence in schizophrenia

Harvard Review of Psychiatry

Volumn 17, Issue 1, 2009, Pages 35-40

  Freudenreich, Oliver ^a,b,c   Tranulis, Constantin ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Freedom Trail Clinic   (United States)

Author keywords

Adherence; Drug attitude; Prototypes; Schizophrenia; Worldview

Indexed keywords

NEUROLEPTIC AGENT;

DOCTOR PATIENT RELATION; HUMAN; MEDICAL DECISION MAKING; MEDICAL EDUCATION; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; AWARENESS; CULTURE; HUMANS; MOTIVATION; PATIENT COMPLIANCE; PERSONALITY ASSESSMENT; PHILOSOPHY; PHYSICIAN-PATIENT RELATIONS; PROGNOSIS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 60749102656     PISSN: 10673229     EISSN: 14657309     Source Type: Journal    
DOI: 10.1080/10673220902724565     Document Type: Review

References (31)

1. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002;63:892-909.
2. Perkins DO. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 2002;63:1121-8.
3. Norman GR, Brooks LR. The non-analytical basis of clinical reasoning. Adv Health Sci Educ Theory Pract 1997;2:173-84.
4. Norman RM, Malla AK. Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol Med 2001;31:381-400.
5. Witteman CL, Harries C, Bekker HL, Van Aarle EJ. Evaluating psychodiagnostic decisions. J Eval Clin Pract 2007;13:10-5.
6. Stern L, Kirmayer LJ. Knowledge structures in illness narratives: development and reliability of a coding scheme. Transcult Psychiatry 2004;41:130-42.
7. Young A. When rational men fall sick: an inquiry into some assumptions made by medical anthropologists. Cult Med Psychiatry 1981;5:317-35.
8. Young A. Rational men and the explanatory model approach. Cult Med Psychiatry 1982;6:57-71.
9. Swanson CL Jr, Freudenreich O, McEvoy JP, Nelson L, Kamaraju L, Wilson WH. Insight in schizophrenia and mania. J Nerv Ment Dis 1995;183:752-5.
10. McEvoy JP, Schooler NR, Friedman E, Steingard S, Allen M. Use of psychopathology vignettes by patients with schizophrenia or schizoaffective disorder and by mental health professionals to judge patients' insight. Am J Psychiatry 1993;150:1649-53.
11. Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 1983;13:177-83.
12. Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. J Clin Psychiatry 2004;65:1372-6.
13. Nicholi Jr AM. Introduction: definition and significance of a worldview. In: Josephson AM, Peteet JR, eds. Handbook of spirituality and worldview in clinical practice. Washington, DC: American Psychiatric Publishing, 2004:3-12.
14. Kleinman A. Patients and healers in the context of culture: an exploration of the borderland between anthropology, medicine, and psychiatry. Berkeley: University of California Press, 1980.
15. Weiss M. Explanatory Model Interview Catalogue (EMIC): framework for comparative study of illness. Transcult Psychiatry 1997;34:235-63.
16. Lewis AJ. The psychopathology of insight. Br J Med Psychol 1934;14:332-48.
17. Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM. Assessment of insight in psychosis. Am J Psychiatry 1993;150:873-9.
18. Birchwood M, Smith JS, Drury V, Healy J, Macmillan F, Slade M. A self-report insight scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatr Scand 1994;89:62-7.
19. Kontos N, Querques J, Freudenreich O. The problem of the psychopharmacologist. Acad Psychiatry 2006;30:218-26.
20. Read J, Haslam N, Sayce L, Davies E. Prejudice and schizophrenia: a review of the 'mental illness is an illness like any other' approach. Acta Psychiatr Scand 2006;114:303-18.
21. Perkins DO, Gu H, Weiden PJ, McEvoy JP, Hamer RM, Lieberman JA. Comparison of Atypicals in First Episode study group. Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study. J Clin Psychiatry 2008;69:106-13.
22. Cather C, Penn D, Otto MW, Yovel I, Mueser KT, Goff DC. A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophr Res 2005;74:201-9.
23. Coldham EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand 2002;106:286-90.
24. Arango C, Kahn R. Progressive brain changes in schizophrenia. Schizophr Bull 2008;34:310-1.
25. Falloon IRH. Antipsychotic drugs: when and how to withdraw them? Psychother Psychosom 2006;75:133-8.
26. Gaebel W, Janner M, Frommann N, et al. First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies. Schizophr Res 2002;53:145-59.
27. Cooke MA, Peters ER, Kuipers E, Kumari V. Disease, deficit or denial? Models of poor insight in psychosis. Acta Psychiatr Scand 2005;112:4-17.
28. Koren D, Poyurovsky M, Viksman P, et al. 2004. The course and nature of insight change in recent-onset schizophrenia: from unawareness to disagreement. Schizophr Res 2004;70(suppl 1):120.
29. Amador X. I am not sick; I don't need help. Peconic, NY: Vida, 2000.
30. Angermeyer MC, Dietrich S. Public beliefs about and attitude towards people with mental illness: a review of population studies. Acta Psychiatr Scand 2006;113:163-79.
31. Linden M, Godemann F. The differentiation between "lack of insight" and "dysfuntional health beliefs" in schizophrenia. Psychopathol 2007;40:236-41.